Christopher E. Pelloski

6.4k total citations
35 papers, 2.2k citations indexed

About

Christopher E. Pelloski is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Christopher E. Pelloski has authored 35 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Christopher E. Pelloski's work include Glioma Diagnosis and Treatment (7 papers), Advanced Radiotherapy Techniques (7 papers) and Studies on Chitinases and Chitosanases (5 papers). Christopher E. Pelloski is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Advanced Radiotherapy Techniques (7 papers) and Studies on Chitinases and Chitosanases (5 papers). Christopher E. Pelloski collaborates with scholars based in United States, South Korea and Canada. Christopher E. Pelloski's co-authors include Kenneth Aldape, Howard Colman, Erik P. Sulman, Mark R. Gilbert, Alicia Rivera, B. Nebiyou Bekele, C. Cruz, Dima Suki, Shiao Y. Woo and Frederick F. Lang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Christopher E. Pelloski

34 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Pelloski United States 17 1.1k 847 540 532 439 35 2.2k
Pierre-Yves Dietrich Switzerland 13 942 0.9× 1.5k 1.7× 569 1.1× 624 1.2× 536 1.2× 14 2.5k
Fréderic Fina France 27 893 0.8× 719 0.8× 506 0.9× 687 1.3× 389 0.9× 87 2.2k
Benoît Lhermitte France 18 821 0.7× 1.1k 1.3× 647 1.2× 710 1.3× 702 1.6× 77 2.5k
Ronald van Marion Netherlands 23 745 0.7× 587 0.7× 644 1.2× 391 0.7× 571 1.3× 54 1.8k
H. S. Friedman United States 21 907 0.8× 969 1.1× 330 0.6× 627 1.2× 625 1.4× 50 2.4k
Jennifer S. Yu United States 24 1.2k 1.1× 823 1.0× 569 1.1× 869 1.6× 826 1.9× 91 2.6k
Stephen Hunter United States 22 773 0.7× 635 0.7× 480 0.9× 414 0.8× 202 0.5× 49 2.0k
Delphine Loussouarn France 28 976 0.9× 337 0.4× 574 1.1× 694 1.3× 629 1.4× 76 2.3k
Siham Sabri Canada 26 569 0.5× 397 0.5× 525 1.0× 603 1.1× 337 0.8× 57 2.0k
Mehdi Touat France 19 835 0.8× 800 0.9× 444 0.8× 688 1.3× 440 1.0× 74 2.1k

Countries citing papers authored by Christopher E. Pelloski

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Pelloski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Pelloski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Pelloski more than expected).

Fields of papers citing papers by Christopher E. Pelloski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Pelloski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Pelloski. The network helps show where Christopher E. Pelloski may publish in the future.

Co-authorship network of co-authors of Christopher E. Pelloski

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Pelloski. A scholar is included among the top collaborators of Christopher E. Pelloski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Pelloski. Christopher E. Pelloski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Changxian, Doris A. Phelps, Hakan Çam, et al.. (2013). Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks. Cancer Research. 73(11). 3393–3401. 74 indexed citations
2.
Lu, Lanchun, et al.. (2013). Using NanoDot dosimetry to study the RS 2000 X-ray Biological Irradiator. International Journal of Radiation Biology. 89(12). 1094–1099. 11 indexed citations
3.
Price, Richard L., Katherine Bingmer, Lualhati Harkins, et al.. (2012). Cytomegalovirus Infection Leads to Pleomorphic Rhabdomyosarcomas in Trp53 +/− Mice. Cancer Research. 72(22). 5669–5674. 38 indexed citations
4.
Hadziahmetovic, Mersiha, Lanchun Lu, J. Leigh Leasure, et al.. (2012). The application of radiation therapy to the pediatric preclinical testing program (PPTP): Results of a pilot study in rhabdomyosarcoma. Pediatric Blood & Cancer. 60(3). 377–382. 10 indexed citations
5.
Radawski, Jeffrey D., Dongqing Zhang, J.C. Grecula, et al.. (2012). Her2-enriched breast cancer brain metastases exhibit resistance to Gamma Knife radiosurgery: findings from a single institutional series review. Journal of Radiation Oncology. 1(3). 283–290. 1 indexed citations
6.
Lu, Lanchun, et al.. (2012). NanoDots Dosimetry for RS 2000 X-Ray Biological Irradiator. International Journal of Radiation Oncology*Biology*Physics. 84(3). S856–S856. 3 indexed citations
7.
Rivera, Andreana L. & Christopher E. Pelloski. (2010). Diagnostic and prognostic molecular markers in common adult gliomas. Expert Review of Molecular Diagnostics. 10(5). 637–649. 3 indexed citations
8.
Rivera, Alicia, Christopher E. Pelloski, Mark R. Gilbert, et al.. (2009). MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-Oncology. 12(2). 116–121. 319 indexed citations
9.
Torres, Mylin A., Eric L. Chang, Anita Mahajan, et al.. (2009). Optimal Treatment Planning for Skull Base Chordoma: Photons, Protons, or a Combination of Both?. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1033–1039. 34 indexed citations
10.
Colman, Howard, Lin Zhang, Erik P. Sulman, et al.. (2009). A multigene predictor of outcome in glioblastoma. Neuro-Oncology. 12(1). 49–57. 285 indexed citations
11.
Rivera, Andreana L., Christopher E. Pelloski, Erik P. Sulman, & Ken Aldape. (2008). Prognostic and Predictive Markers in Glioma and Other Neuroepithelial Tumors. Current Problems in Cancer. 32(3). 97–123. 11 indexed citations
12.
Mahajan, Anita, Shiao Y. Woo, David Kornguth, et al.. (2008). Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohort. Pediatric Blood & Cancer. 50(5). 976–982. 49 indexed citations
13.
Pelloski, Christopher E., Karla V. Ballman, Alfred Furth, et al.. (2007). Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma. Journal of Clinical Oncology. 25(16). 2288–2294. 239 indexed citations
14.
Sulman, Erik P., Christopher E. Pelloski, J. Matthew McDonald, et al.. (2007). Podoplanin expression is an independent predictor of survival in malignant gliomas. Cancer Research. 67. 2438–2438. 1 indexed citations
15.
Pelloski, Christopher E. & Mark R. Gilbert. (2007). Current Treatment Options in Adult Glioblastoma. 105–105. 4 indexed citations
16.
Colman, Howard, Caterina Giannini, Li Huang, et al.. (2006). Assessment and Prognostic Significance of Mitotic Index Using the Mitosis Marker Phospho-histone H3 in Low and Intermediate-grade Infiltrating Astrocytomas. The American Journal of Surgical Pathology. 30(5). 657–664. 114 indexed citations
17.
Pelloski, Christopher E., Matthew Palmer, Gregory M. Chronowski, et al.. (2005). Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 62(1). 131–137. 117 indexed citations
18.
Gifford, Kent A., John L. Horton, Christopher E. Pelloski, et al.. (2005). A three-dimensional computed tomography–assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. International Journal of Radiation Oncology*Biology*Physics. 63(2). 615–621. 11 indexed citations
19.
Pelloski, Christopher E., et al.. (2001). Clinical stage IEA–IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiotherapy and Oncology. 59(2). 145–151. 39 indexed citations
20.
Venta, Luz A., et al.. (1999). Management of complex breast cysts.. American Journal of Roentgenology. 173(5). 1331–1336. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre-Yves Dietrich Breakdown of academic impact, for papers by Fréderic Fina Breakdown of academic impact, for papers by Benoît Lhermitte Breakdown of academic impact, for papers by Ronald van Marion Breakdown of academic impact, for papers by H. S. Friedman Breakdown of academic impact, for papers by Jennifer S. Yu Breakdown of academic impact, for papers by Stephen Hunter Breakdown of academic impact, for papers by Delphine Loussouarn Breakdown of academic impact, for papers by Siham Sabri Breakdown of academic impact, for papers by Mehdi Touat
Rankless by CCL
2026